---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-25-000010"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T10:06:02.586121+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed reports record FY2024 revenue $158M; Q4 margins compress, adjusted EBITDA up in Q4

## Summary
- Q4 2024 revenue $39.0M (vs $38.9M); full-year revenue $158.0M (+6.3% YoY).
- GAAP gross margin fell to 33% in Q4 from 45% YoY; full-year margin 40% vs 44%.
- Full-year GAAP net loss improved to $12.1M from $16.0M; adjusted EBITDA $19.6M vs $24.7M.
- Wholesale revenue up 29% annually; Betty's Eddies top-selling edible in MA and MD.
- CEO cites 10 revenue-generating assets added over past two years for 2025 growth.

## SEC filing metadata
- accession: 0001522767-25-000010
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000010/0001522767-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000010/mrmd-20250305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-25-000010
- JSON: https://secwatch.observer/filing/0001522767-25-000010.json
- Plain text: https://secwatch.observer/filing/0001522767-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.